TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Bafna Pharmaceuticals Limited ( (IN:BAFNAPH) ) is now available.
Bafna Pharmaceuticals Limited has completed the sale of its manufacturing unit located in Madhavaram, Chennai, to Navron Pharma Private Limited. This transaction, finalized on June 30, 2025, was approved by the company’s Board of Directors and shareholders, and it marks a strategic move to streamline operations. The sale, which is not a related party transaction, involved a consideration of Rs. 1,45,13,260 and represents a minor portion of the company’s revenue and net worth, contributing 0.08% and 1.55% respectively. This move is expected to impact the company’s operational focus and potentially enhance its financial positioning.
More about Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is based in Chennai, India, and is known for its manufacturing capabilities in the pharmaceutical sector.
Average Trading Volume: 1,038
Current Market Cap: 1.85B INR
For an in-depth examination of BAFNAPH stock, go to TipRanks’ Overview page.